Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Action Potential Venture Capital

Status
ACTIVE
Global HQ
Scotts Valley, USA
Countries of investment
  • USA
  • Canada
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotechnology
  • Pharma
  • Medical Devices
  • Digital Health
About
Action Potential Venture Capital (APVC) is a leading medtech venture capital firm founded by GSK in 2013. APVC invests globally in startups advancing bioelectronic medicines and enabling technologies. They actively support innovation in neural interfacing and electroceuticals.
Min check size
$100K
Max check size
$30M
Fund size
NPS

Investment Thesis

APVC is dedicated to bringing bioelectronic medicines to patients by supporting innovators and entrepreneurs pioneering a bioelectronic future.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Top-tier fund concentrating on early-stage biotechnology and healthcare ventures. Engaged in over 30 investments primarily in the US, with a notable focus on companies that demonstrate innovative therapeutic solutions. Recognized for a hands-on, operator-led approach and a successful track record of multiple high-profile IPOs. Committed to fostering strong partnerships with emerging entrepreneurs to drive growth and value creation.

Action Potential Venture Capital Contacts Information

Primary contact

Secondary contact

Team

Jua

Imran Eba

Portfolio

Alpheus Medical

Cala Health

CVRx

Exo Imaging

MicroTransponder

Neuspera

Onc AI

Presidio Medical

Saluda Medical

SetPoint Medical.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp